NCT06325696View on ClinicalTrials.gov

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

PHASE2RecruitingINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisLung Diseases, Interstitial
Interventions
DRUG

hymecromone

400 mg

Trial Locations (1)

27709

RECRUITING

NIEHS Clinical Research Unit (CRU), Research Triangle Park

All Listed Sponsors
lead

National Institute of Environmental Health Sciences (NIEHS)

NIH